CYP cynata therapeutics limited
Add to My Watchlist 8.82% ! 15.5¢

Stem Cell News, page-460

  1. pfeifer1982
    1,315 Posts.
    lightbulb Created with Sketch. 3973
    clock Created with Sketch.
    27/02/23
    10:48
    Post #: 66481118
    Great to see more iPSC clinical trials being cleared and taking place in the US.

    I don't think the spokesperson (CEO) is incorrect.

    From what I can see, IPS HEART's clinical trials attempt to regenerate/regrow muscle - skeletal muscle (DMD / GIVI-MPC) and heart muscle (heart attack / ISX9-CPC). The press release mentions that even the newer (non-IPS) gene therapies "cannot create any new skeletal muscle".

    I would not consider Cynata's FDA cleared IND application or Fate's past, ongoing clinicial trials or FDA cleared IND applications to be disease-modifying.

    Cynata has a disease modifying therapy in the form of CYP-004, "SCUlpTOR - Stem Cells as a symptom- and strUcture-modifying Treatment for medial tibiofemoral OsteoaRthritis", which is however taking place in Australia, not the US.

    At this stage, IPS HEART would be the first iPSC disease-modifying clinical trial in the US as far as I can see.
    CYP Price at posting: 32.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 8  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS 'Strong succession': WiseTech brings in old face to build new, post-White future
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
15.5¢ 		Change
-0.015(8.82%) 		Mkt cap ! $35.02M
Open High Low Value Volume
17.0¢ 17.0¢ 15.5¢ $35.01K 213.1K

Buyers (Bids)

No. Vol. Price($)
4 201289 15.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 14675 1
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.